{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:53Z","timestamp":1747181153968,"version":"3.40.5"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Erdheim-Chester disease (ECD) is a rare progressive disease affecting multiple systems. It has recently been recognized as a neoplastic disease following the discovery of activating mutations in the MAPK pathway. There are several striking signs of ECD, such as the long bone involvement, as well as the hairy kidney appearance on computed tomography scan. It is rare for ECD to manifest neurological symptoms. Central nervous system involvement is a strong prognostic factor and independent predictor of death. ECD is characterized by the overproduction and accumulation of foamy histiocytes and Touton\u2019s giant cells in various tissues and organs. ECD is a multisystem disorder in which any organ may be affected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>This case report describes a 57-year-old woman with headaches and ataxia as the first clinical manifestation, without characteristic bone pain, but with delayed enuresis. In addition to the renal involvement, this patient had rarer splenic involvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The imaging presentation of this patient was similar to that of a \u201cmultiple meningiomas\u201d. A combination of clinical, imaging and pathology for the diagnosis of ECD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Patients were given INF-\u03b1 therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Fortunately, the patient responded well to INF-\u03b1 treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>ECD patient with neuro-endocrine symptoms.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033846","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:00:53Z","timestamp":1684450853000},"page":"e33846","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation"],"prefix":"10.1097","volume":"102","author":[{"given":"Liuze","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of Jilin University, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rihua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanglin","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8764-6547","authenticated-orcid":false,"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","article-title":"Erdheim-chester disease. Clinical and radiologic characteristics of 59 cases.","volume":"75","author":"Veyssier-Belot","year":"1996","journal-title":"Medicine (Baltim)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1750-1172-8-137","article-title":"Erdheim-chester disease: a comprehensive review of the literature.","volume":"8","author":"Mazor","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1308\/rcsann.2019.0130","article-title":"A rare differential for sinusitis and visual loss.","volume":"102","author":"Lee","year":"2020","journal-title":"Ann R Coll Surg Engl"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood.2020005101","article-title":"High frequency of clonal hematopoiesis in Erdheim-Chester disease.","volume":"137","author":"Cohen Aubart","year":"2021","journal-title":"Blood"},{"key":"R6-20250504","first-page":"397","article-title":"Neurologic presentation of Erdheim-Chester disease.","volume":"40","author":"Brodkin","year":"2006","journal-title":"Neurol Neurochir Pol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e04808","DOI":"10.1002\/ccr3.4808","article-title":"Lymphomatoid granulomatosis of the central nervous system (CNS-LYG) posing a management challenge.","volume":"9","author":"Soleja","year":"2021","journal-title":"Clin Case Rep"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3857\/roj.2021.01074","article-title":"Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease.","volume":"40","author":"Prasad","year":"2022","journal-title":"Radiat Oncol J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/TP.0b013e3182762e07","article-title":"Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.","volume":"95","author":"Tiede","year":"2013","journal-title":"Transplantation"},{"key":"R10-20250504","first-page":"e21850","article-title":"IgG4-related disease presenting as hypertrophic pachymeningitis.","volume":"14","author":"Sapkota","year":"2022","journal-title":"Cureus"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11547-020-01226-7","article-title":"MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature.","volume":"126","author":"Varrassi","year":"2021","journal-title":"Radiol Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/art.22165","article-title":"Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients.","volume":"54","author":"Haroche","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.semarthrit.2011.11.004","article-title":"Treatment of Erdheim-Chester disease with long-term high-dose interferon-alpha.","volume":"41","author":"Hervier","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"R14-20250504","first-page":"vdaa024","article-title":"Dual BRAF\/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy.","volume":"2","author":"Mazor","year":"2020","journal-title":"Neurooncol Adv"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:03:40Z","timestamp":1746324220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":14,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033846","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}